Stem Cell Therapy Market

Stem Cell Therapy Market Size, Share & Trends Analysis Report

Stem Cell Therapy Market Size Share Companies & Trends Analysis Report By Type (Allogeneic Stem Cell Therapy Market, By Application (Musculoskeletal Disorders, Wounds and Injuries, Surgeries, Acute Graft-Versus-Host Disease (AGVHD), Other Applications), Autologous Market, By Application (Wounds and Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, Other Applications)), By Therapeutic Application (Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells, Other Cell Sources) , Based On Region And Segment Forecasts 2022 - 2028

Report ID : BMRC 1246
Number of pages : 300
Published Date : Nov 2022
Category : Healthcare
Delivery Timeline : 48 hrs

Stem Cell Therapy Market is valued at USD 197.30 Million in 2021 and expected to reach USD 554.25 Million by 2028 with the CAGR of 15.90% over the forecast period.

Rising prevalence of chronic diseases, increasing spend on research & development and increasing collaboration between industry and academia driving the growth of stem cell therapy market. 


Stem cells therapy also known as regenerative medicine therapy, stem-cell therapy is the use of stem cells to prevent or treat the condition or disease. Stem cell are the special type of cells those differentiated from other type of cell into two defining characteristics including the ability to differentiate into a specialized adult cell type and perpetual self-renewal. Under the appropriate conditions in the body or a laboratory stem cells are capable to build every tissue called daughter cells in the human body; hence these cells have great potential for future therapeutic uses in tissue regeneration and repair. Among stem cell pluripotent are the type of cell that can become any cell in the adult body, and multipotent type of cell are restricted to becoming a more limited population of cells.

The stem cell therapy has been used to treat people with conditions including leukemia and lymphoma, however this is the only form of stem-cell therapy which is widely practiced. Prochymal are another stem-cell therapy was conditionally approved in Canada in 2012 for the treatment of acute graft-vs-host disease in children those are not responding to steroids. Nevertheless, hematopoietic stem cell transplantation is the only established therapy using stem cells. This therapy involves the bone marrow transplantation.

Stem cell therapy market report is segmented based on type, therapeutic application, cell source and by regional & country level. Based upon type, stem cell therapy market is classified into allogeneic stem cell therapy market and autologous market.

Based upon therapeutic application, stem cell therapy market is classified into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases and other applications. Based upon cell source, stem cell therapy market is classified into adipose tissue-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells, cord blood/embryonic stem cells and other cell sources

The regions covered in this stem cell therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of stem cell therapy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.


Stem cell therapy market report covers prominent players like,

  • Osiris Therapeutics, Inc
  • Anterogen, Ltd.
  • Cynata
  • Pharmicell
  • Cytori Therapeutics
  • Holostem Terapie Avanzate S.r.l.
  • JCR Pharmaceuticals
  • NuVasive
  • RTI Surgical
  • STEMCELL Technologies
  • Osiris Therapeutics
  • Human Longevity
  • Advanced Cell Technology
  • Promethera Biosciences
  • Mesoblast and AlloSource 
  • others


By Type

  • Allogeneic Stem Cell Therapy Market, By Application

    • Musculoskeletal Disorders
    • Wounds and Injuries
    • Surgeries
    • Acute Graft-Versus-Host Disease (AGVHD)
    • Other Applications
  • Autologous Market, By Application

    • Wounds and Injuries
    • Cardiovascular Diseases
    • Gastrointestinal Diseases
    • Other Applications

By Therapeutic Application

  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cardiovascular Diseases
  • Surgeries
  • Gastrointestinal Diseases
  • Other Applications

By Cell Source

  • Adipose Tissue-Derived Mesenchymal Stem Cells
  • Bone Marrow-Derived Mesenchymal Stem Cells
  • Cord Blood/Embryonic Stem Cells
  • Other Cell Sources

By Region

North America

• U.S.
• Canada


• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe


• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• Egypt
• South Africa
• Rest Of MEA

Market Dynamics–

Rising spend on research and development activities in the research institutes and biotech industries driving the growth of the stem cell therapy market during the forecast period. For instance, in January 2010, U. S. based Augusta University initiated Phase I clinical trial to evaluate the safety and effectiveness of a single, autologous cord blood stem infusion for treatment of cerebral palsy in children. The study is estimated to complete in July 2020. Additionally, increasing prevalence of chronic diseases creating the demand of stem cell therapy. For instance, as per the international diabetes federation, in 2019, around 463 million population across the world were living with diabetes; by 2045 it is expected to rise around 700 million. Among all 79% of population with diabetes were living in low- and middle-income countries. These all factors are fuelling the growth of market over the forecast period. On the other flip, probabilities of getting success is less in the therapeutics by stem cell may restrain the growth of market. Nevertheless, Advancement of technologies and government initiative to encourage research in stem cell therapy expected to create lucrative opportunity in stem cell therapy market over the forecast period.

Regional Analysis–

North America is dominating the stem cell therapy market due increasing adoption rate of novel stem cell therapies fueling the growth of market in the region. Additionally, favorable government initiatives have encouraging the regional market growth. For instance, government of Canada has initiated Strategic Innovation Fund Program, in which gov will invests in research activities carried out for stem cell therapies. In addition, good reimbursing scheme in the region helping patient to spend more on health. Above mentioned factors are expected to drive the North America over the forecast period.

Asia Pacific is anticipated to grow at a highest CAGR over forecast period due to rising awareness of benefits of stem cell therapies among the population. In addition, increasing collaboration between industry-academia to initiate research and development in the stem cell therapy expected to create the huge growth over the forecast period. For instance, as per the report of Pharma Focus Asia, members of Asia-Pacific Economic Cooperation collaborated with Life Sciences Innovation Forum to involve professionals having expertise in stem cell therapies from academia and research centers to promote developments in stem cell research which will foster regional market growth.

Report Analysis Details
Historical data 2018 - 2021
Forecast Period 2022 - 2028
Market Size in 2021: USD 197.30 Million 
Base year considered 2021
Forecast Period CAGR %:


Market Size Expected in 2028: USD 554.25 Million 
Tables, Charts & Figures: 175
Pages 200
Companies Osiris Therapeutics, Inc, MEDIPOST, Anterogen, Ltd., Cynata, Pharmicell, Cytori Therapeutics, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, NuVasive, RTI Surgical, STEMCELL Technologies, BIOTIME, Osiris Therapeutics, Human Longevity, Advanced Cell Technology, Promethera Biosciences, Mesoblast and AlloSource , others
Segments Covered By Type, By Therapeutic Application, By Cell Source
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits

  • Global Stem Cell Therapy Market report covers in depth historical and forecast analysis.
  • Global Stem Cell Therapy Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Stem Cell Therapy Market report helps to identify opportunities in market place.
  • Global Stem Cell Therapy Market report covers extensive analysis of emerging trends and competitive landscape.